Photoelectron Corporation (PECN) Fair Value & Analysis
Healthcare · US · Market cap $20.1M
Fair value as of: Jun 23, 2026
Analysis
Photoelectron Corporation (PECN) currently trades at $1.02, while our model-based Fair Value estimate is $0.1800 — implying the stock looks roughly 82.3% overvalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Photoelectron Corporation, a technology company, engages in the development, manufacture, and marketing of miniature x-ray systems for multiple market applications. It creates and adapts miniature x-ray systems for various applications in healthcare and nonhealthcare related markets. The company offers micro-adaptive x-ray systems designed for x-ray fluorescence analysis, intravascular radiation therapy, brachytherapy, radiosurgery, intraoperative radiation therapy, and instrumentation to the industrial and medical markets through original equipment manufacturers. Photoelectron Corporation was founded in 1989 and is based in North Billerica, Massachusetts.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Photoelectron Corporation (PECN) undervalued?
What is the fair value of PECN?
What is the quality score of PECN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.